Related Experiment Videos
Scleroderma with cardiac tamponade, hyperthyroidism and incidental papillary thyroid carcinoma
R M Gokula1, A K Gupta, S E Shirley
1Mandeville Public Hospital, Mandeville, Manchester and, University Hospital of the West Indies, Kingston, 7, Jamaica, West Indies.
The West Indian Medical Journal
|December 28, 2002
Summary
Progressive Systemic Sclerosis (PSS) patients with cardiac tamponade and malignancy face poor prognosis. This case highlights a patient with PSS and thyroid neoplasm who recovered well after pericardiocentesis for cardiac tamponade.
Area of Science:
- Cardiology
- Rheumatology
- Endocrinology
Background:
- Progressive Systemic Sclerosis (PSS) is a multisystem autoimmune disease.
- Cardiac tamponade and malignancy are recognized as indicators of poor prognosis in PSS.
- Thyroid neoplasms can occur in patients with autoimmune diseases.
Observation:
- A 31-year-old African-Jamaican woman with PSS presented with cardiac tamponade.
- The patient also had a concurrent diagnosis of a thyroid neoplasm.
- Pericardiocentesis was performed to relieve the cardiac tamponade.
Findings:
- The patient had two significant poor prognostic markers: cardiac tamponade and malignancy.
- Despite these markers, the patient experienced a favorable postoperative recovery.
- This suggests potential for better outcomes than typically expected in such cases.
Implications:
- This case challenges the universally poor prognosis associated with combined cardiac tamponade and malignancy in PSS.
- It underscores the importance of individualized patient management and timely intervention.
- Further research may explore factors contributing to favorable outcomes in complex PSS cases.